Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 4, 2009, Pages 443-447

  Saresella, M ^a   Rolland, A ^b   Marventano, I ^a   Cavarretta, R ^a   Caputo, D ^a   Marche, P ^b   Perron, H ^c,d   Clerici, Mario ^a,e  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b CEA GRENOBLE   (France)

^c GENEURO SA   (Switzerland)

^d University of Milano ^*

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Cytokines; ENV SU protein; Human endogenous retroviruses (HERV); Immunology; Multiple sclerosis; T lymphocytes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; ENDOGENOUS RETROVIRUS; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS ASSOCIATED RETROVIRAL AGENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION;

ACUTE DISEASE; ADULT; ANTIGENS, CD14; ANTIGENS, CD3; CYTOKINES; ENDOGENOUS RETROVIRUSES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 63449138123     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508100840     Document Type: Article

References (21)

1. Martin, R, McFarland, HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995; 32: 121-182.
2. Steinman, L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85: 299-302.
3. Olsson, T, Zhi, WW, Höjeberg, B, et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest 1990; 86: 981-985.
4. Navikas, V, He, B, Link, J, et al. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996; 119: 213-223.
5. Ferrante, P, Fusi, ML, Saresella, M, et al. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. J Immunol 1998; 160: 1514-1521.
6. Clerici, M, Saresella, M, Trabattoni, D, et al. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J Neuroimmunol 2001; 121: 88-101.
7. Perron, H, Geny, C, Laurent, A, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989; 140: 551-561.
8. Perron, H, Lalande, B, Gratacap, B, et al. Isolation of retrovirus from patients with multiple sclerosis. Lancet 1991; 337: 862-863.
9. Dolei, A, Serra, C, Mameli, G, et al. Multiple sclerosisassociated retrovirus (MSRV) in Sardinian MS patients. Neurology 2002; 58: 471-473.
10. Garson, JA, Tuke, PW, Giraud, P, Paranhos-Baccala, G, Perron, H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 1998; 351: 33.
11. Serra, C, Sotgiu, S, Mameli, G, Pugliatti, M, Rosati, G, Dolei, A. Multiple sclerosis and multiple sclerosisassociated retrovirus in Sardinia. Neurol Sci 2001; 22: 171-173.
12. Sotgiu, S, Serra, C, Mameli, G, et al. Multiple sclerosisassociated retrovirus and MS prognosis: An observational study. Neurology 2002; 59: 1071-1073.
13. Perron, H, Jouvin-Marche, E, Michel, M, et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 2001; 2873: 21-32.
14. Serra, C, Mameli, G, Arru, G, Sotgiu, S, Rosati, G, Dolei, A. In vitro modulation of the multiple sclerosis (MS)- associated retrovirus by cytokines: Implications for MS pathogenesis. J Neurovirol 2003; 9: 637-643.
15. Rolland, A, Jouvin-Marche, E, Saresella, M, et al. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis. J Neuroimmunol 2005; 160: 195-203.
16. Blond, JL, Beseme, F, Duret, L, et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999; 73: 1175-1185.
17. Komurian-Pradel, F, Paranhos-Baccala, G, Bedin, F, et al. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 1999; 260: 1-9.
18. Perron, H, Garson, JA, Bedin, F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A 1997; 14: 7583-7588.
19. Perron, H, Gratacap, B, Lalande, B, et al. In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient. Res Virol 1992; 143: 337-350.
20. Perron, H, Perin, JP, Rieger, F, Alliel, PM. Particleassociated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a "chain-reaction" triggered by infectious agents in multiple sclerosis. J Neurovirol 2000; 2: S67-S75.
21. Rolland, A, Jouvin-Marche, E, Viret, C, Faure, M, Perron, H, Marche, PN. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 2006; 176: 7636-7644.